Fujifilm Announces New Platform in Digital Mammography Portfolio – Amulet
Innovality* at RSNA 2013
RSNA 2013 (Booth #2539 South Building)
STAMFORD, Conn. -- December 1, 2013
Today at the 99^th annual meeting of the Radiological Society of North America
(RSNA), FUJIFILM Corporation, Tokyo, Japan, introduced its latest and most
innovative digital mammography system, the Amulet Innovality* in Chicago, IL.
The Amulet Innovality is not commercially available in the United States. When
it becomes available in the US it will be named the Aspire Cristalle**.
“Our newest full field digital mammography system is brilliantly designed to
offer both 2D and advanced applications for the most confident diagnoses,”
said David Hotchkiss, director of marketing, Women’s Health, CR, FUJIFILM
Medical Systems U.S.A., Inc. “Now the radiologist can see breast tissue detail
in a way that was never seen before in sharper, clearer images and can make
confident diagnostic interpretations.”
Among the many new features of the Amulet Innovality**** is the ability of
this system to utilize advanced applications which includes the ability to do
breast tomosynthesis studies***. Since launching CR products, Fujifilm has
demonstrated a commitment to introducing innovative, meaningful technology
that will enable our customers to diagnose breast cancer earlier and save more
lives. Fujifilm will continue to provide those breakthrough innovations as it
increasingly invests in new approaches to breast imaging. The Amulet
Innovality also has been designed to enhance patient comfort and the patient
experience during annual exams.
To register for a product demonstration at RSNA, please visit
http://rsna.fujimed.com. For every product demonstration registered online,
Fujifilm will donate $25 to the National Breast Cancer Foundation. For more
information about Fujifilm’s Aspire Breast Imaging Solutions, please visit:
FUJIFILM Medical Systems U.S.A., Inc. is a leading provider of diagnostic
imaging products and medical informatics solutions to meet the needs of
healthcare facilities today and well into the future. From a broad selection
of digital x-ray systems, to the Synapse® brand of PACS, RIS and
cardiovascular products, to advanced women’s health imaging systems, Fujifilm
has products that are ideal for any size imaging environment. The Endoscopy
Division of FUJIFILM Medical Systems U.S.A., Inc. supplies high quality,
technologically advanced FUJINON brand endoscopes to the medical market.
FUJIFILM Medical Systems U.S.A., Inc. is headquartered in Stamford, CT. For
more information, please visit www.fujimed.com and www.fujifilmendoscopy.com.
FUJIFILM Holdings Corporation, Tokyo, Japan, brings continuous innovation and
leading-edge products to a broad spectrum of industries, including electronic
imaging, digital printing equipment, medical systems, life sciences, graphic
arts, flat panel display materials, and office products, based on a vast
portfolio of digital, optical, fine chemical and thin film coating
technologies. The company was among the top 10 companies around the world
granted U.S. patents in 2012, and in the year ended March 31, 2013, had global
revenues of $26.7 billion*. Fujifilm is committed to environmental stewardship
and good corporate citizenship. For more information, please visit
* At an exchange rate of 83 yen to the dollar.
*The Amulet Innovality is not commercially available in the United States
** The ASPIRE Cristalle will be made commercially available in the United
States upon receipt of FDA clearance.
Caution: Investigational Device . Limited by U.S. Federal Law to
***Tomosynthesis functionality for ASPIRE Cristalle is not commercially
available in the United States.
****The Amulet Innovality will be known as Aspire Cristalle once available in
the United States
Lauren Geloso, 914-789-8303
Press spacebar to pause and continue. Press esc to stop.